Skip to main content
. Author manuscript; available in PMC: 2015 Feb 23.
Published in final edited form as: Clin Infect Dis. 2006 Apr 26;42(11):1570–1577. doi: 10.1086/503423

Figure 2.

Figure 2

Cumulative percentage of patients with recrudescence (PCR-corrected) following completion of a 4-dose regimen of artemether-lumefantrine. Overall, P = .004.